Bioserve Today:

• Bioserve has recently offered a majority stake to QPS Holding LLC. QPS is a global CRO with operations in The US, The Netherlands, Taiwan and India. QPS offers a diverse range of services including Pre-clinical, DMPK and Phase I, Late stage Clinical services and Bioanalysis
• QPS Bioserve has completed over 550 studies for various pharmaceutical sponsors; Over 130 for regulatory submissions to US FDA, UK MHRA, SA MCC, AUS TGA, WHO, Health Canada and other agencies
• Currently having about 80+ Bioanalytical methods